These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37165488)

  • 1. Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.
    Abu Khalaf R; Abusaad A; Al-Nawaiseh B; Sabbah D; Albadawi G
    Curr Comput Aided Drug Des; 2024; 20(5):564-574. PubMed ID: 37165488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors.
    Abu Khalaf R; Sabbah D; Al-Shalabi E; Bishtawi S; Albadawi G; Abu Sheikha G
    Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29112287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Molecular Modeling of Novel 3,5-Bis(trifluoromethyl) benzylamino Benzamides as Potential CETP Inhibitors.
    Khalaf RA; Awad M; Al-Qirim T; Sabbah D
    Med Chem; 2022; 18(4):417-426. PubMed ID: 34463228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors.
    Khalaf RA; Al-Rawashdeh S; Sabbah D; Abu Sheikha G
    Med Chem; 2017; 13(3):239-253. PubMed ID: 27823564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trifluoromethylated Aryl Sulfonamides as Novel CETP Inhibitors: Synthesis, Induced Fit Docking, Pharmacophore Mapping and Subsequent
    Khalaf RA; Shaiah HA; Sabbah D
    Med Chem; 2023; 19(4):393-404. PubMed ID: 36093822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
    Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
    J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated Diaryl Sulfonamides: Molecular Modeling, Synthesis, and
    Khalaf RA; Shalluf A; Habash M
    Curr Comput Aided Drug Des; 2024; 20(6):987-997. PubMed ID: 37855352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.
    Johns DG; Duffy J; Fisher T; Hubbard BK; Forrest MJ
    Drugs; 2012 Mar; 72(4):491-507. PubMed ID: 22356288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Inhibition of Cholesteryl Ester Transfer Protein by Small Molecule Inhibitors.
    Chirasani VR; Sankar R; Senapati S
    J Phys Chem B; 2016 Aug; 120(33):8254-63. PubMed ID: 27111423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide cores.
    Liu J; Shao PP; Guiadeen D; Krikorian A; Sun W; Deng Q; Cumiskey AM; Duffy RA; Murphy BA; Mitra K; Johns DG; Duffy JL; Vachal P
    Bioorg Med Chem Lett; 2021 Jan; 32():127668. PubMed ID: 33161125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Synthesis, Biological Evaluation, and Cheminformatics Analysis of a Group of Chlorinated Diaryl Sulfonamides: Promising Inhibitors of Cholesteryl Ester Transfer Protein.
    Abu Khalaf R; Lafi A; Hajjo R; Al-Sha'er MA
    Curr Comput Aided Drug Des; 2024 Feb; ():. PubMed ID: 38424428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein (CETP) inhibitors.
    Hunt JA; Lu Z
    Curr Top Med Chem; 2009; 9(5):419-27. PubMed ID: 19519458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein and its inhibition.
    Weber O; Bischoff H; Schmeck C; Böttcher MF
    Cell Mol Life Sci; 2010 Sep; 67(18):3139-49. PubMed ID: 20556633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
    Mohammadpour AH; Akhlaghi F
    Clin Pharmacokinet; 2013 Aug; 52(8):615-26. PubMed ID: 23658137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor.
    Zhao D; Xie H; Bai C; Liu C; Hao C; Zhao S; Yuan H; Luo C; Wang J; Lin B; Zheng J; Cheng M
    Bioorg Med Chem; 2016 Apr; 24(8):1589-97. PubMed ID: 27010500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention.
    Sirtori CR
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1543-54. PubMed ID: 21961529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and SAR studies of ursolic acid 3β-ester derivatives as novel CETP inhibitors.
    Chen C; Sun R; Sun Y; Chen X; Li F; Wen X; Yuan H; Chen D
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126824. PubMed ID: 31780304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.
    Dong B; Singh AB; Fung C; Kan K; Liu J
    Atherosclerosis; 2014 Aug; 235(2):449-62. PubMed ID: 24950000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizons for cholesterol ester transfer protein inhibitors.
    Schwartz GG
    Curr Atheroscler Rep; 2012 Feb; 14(1):41-8. PubMed ID: 22083134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding profiles of cholesterol ester transfer protein with current inhibitors: a look at mechanism and drawback.
    Yang Z; Cao Y; Hao D; Yuan X; Zhang L; Zhang S
    J Biomol Struct Dyn; 2018 Aug; 36(10):2567-2580. PubMed ID: 28777919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.